Reduced glucocerebrosidase activity in monocytes from patients with Parkinson’s disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Reduced glucocerebrosidase activity in monocytes from patients with Parkinson’s disease ; volume:8 ; number:1 ; day:18 ; month:10 ; year:2018 ; pages:1-12 ; date:12.2018
Scientific reports ; 8, Heft 1 (18.10.2018), 1-12, 12.2018
- Urheber
-
Atashrazm, Farzaneh
- Beteiligte Personen und Organisationen
-
Hammond, Deborah
Perera, Gayathri
Dobson-Stone, Carol
Mueller, Nicole
Pickford, Russell
Kim, Woojin Scott
Kwok, John B.
Lewis, Simon J. G.
Halliday, Glenda M.
Dzamko, Nicolas
SpringerLink (Online service)
- DOI
-
10.1038/s41598-018-33921-x
- URN
-
urn:nbn:de:101:1-2018111717030450485565
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.20252025, 04:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Atashrazm, Farzaneh
- Hammond, Deborah
- Perera, Gayathri
- Dobson-Stone, Carol
- Mueller, Nicole
- Pickford, Russell
- Kim, Woojin Scott
- Kwok, John B.
- Lewis, Simon J. G.
- Halliday, Glenda M.
- Dzamko, Nicolas
- SpringerLink (Online service)
Ähnliche Objekte (12)
Reduced penetrance of Parkinson’s disease models
Reduced habit-driven errors in Parkinson’s Disease
Physical activity profiles in Parkinson’s disease
Transcriptome deregulation of peripheral monocytes and whole blood in GBA-related Parkinson’s disease
Reduced synaptic activity and dysregulated extracellular matrix pathways in midbrain neurons from Parkinson’s disease patients
α-Synuclein-containing erythrocytic extracellular vesicles: essential contributors to hyperactivation of monocytes in Parkinson’s disease
Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson’s disease
Early-stage idiopathic Parkinson’s disease is associated with reduced circular RNA expression
Reduced workforce participation 5 years prior to first Parkinson’s disease sick-leave
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Nutraceuticals in Parkinson’s Disease
Redefinition of Parkinson’s Disease
Reduced penetrance of Parkinson’s disease models
Reduced habit-driven errors in Parkinson’s Disease
Physical activity profiles in Parkinson’s disease
Transcriptome deregulation of peripheral monocytes and whole blood in GBA-related Parkinson’s disease
Reduced synaptic activity and dysregulated extracellular matrix pathways in midbrain neurons from Parkinson’s disease patients
α-Synuclein-containing erythrocytic extracellular vesicles: essential contributors to hyperactivation of monocytes in Parkinson’s disease
Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson’s disease
Early-stage idiopathic Parkinson’s disease is associated with reduced circular RNA expression
Reduced workforce participation 5 years prior to first Parkinson’s disease sick-leave
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Nutraceuticals in Parkinson’s Disease
Redefinition of Parkinson’s Disease
Reduced penetrance of Parkinson’s disease models
Reduced habit-driven errors in Parkinson’s Disease
Physical activity profiles in Parkinson’s disease
Transcriptome deregulation of peripheral monocytes and whole blood in GBA-related Parkinson’s disease
Reduced synaptic activity and dysregulated extracellular matrix pathways in midbrain neurons from Parkinson’s disease patients
α-Synuclein-containing erythrocytic extracellular vesicles: essential contributors to hyperactivation of monocytes in Parkinson’s disease
Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson’s disease
Early-stage idiopathic Parkinson’s disease is associated with reduced circular RNA expression
Reduced workforce participation 5 years prior to first Parkinson’s disease sick-leave
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Nutraceuticals in Parkinson’s Disease